Article
New insights on the pathogenesis of ovarian carcinoma: molecular basis and clinical implications.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology - 1 Aug 2012
Gadducci Angiolo, Guerrieri Maria Elena, Genazzani Andrea Riccardo
Abstract excerpt
Ovarian carcinoma can be subdivided into two categories termed type I and type II. Type I tumours, usually having an indolent clinical behaviour, are often detected in early stage, and rarely harbour p53 gene mutations. Each histological type has a distinct molecular profile with mutations of genes involved in different signalling transduction pathways, such as KRAS, BRAF, CTNNB1, PTEN, PIK3CA and ARID1A. Type II...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
